Corvus Pharmaceuticals (CRVS) Soars 212% in Impressive Eczema Therapy Study
We recently published 10 Stocks With Effortless Double- and Triple-Digit Gains. Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) was one of the top performers last week. Corvus Pharmaceuticals soared 211.8 percent weekly to hit a new all-time high, as investors cheered strong results from its clinical trial testing the effectiveness of soquelitinib in patients with moderate to severe…